BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30363714)

  • 1. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
    Jia Y; Zhao L; Wang C; Shang J; Miao Y; Dong Y; Zhao Z
    Dis Markers; 2018; 2018():4528547. PubMed ID: 30363714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
    Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
    Förger F; Matthias T; Oppermann M; Becker H; Helmke K
    Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC; Ho LY; Leung HW; Wong LG
    Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
    Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
    Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
    J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q antibodies in systemic lupus erythematosus.
    Orbai AM; Truedsson L; Sturfelt G; Nived O; Fang H; Alarcón GS; Gordon C; Merrill J; Fortin PR; Bruce IN; Isenberg DA; Wallace DJ; Ramsey-Goldman R; Bae SC; Hanly JG; Sanchez-Guerrero J; Clarke AE; Aranow CB; Manzi S; Urowitz MB; Gladman DD; Kalunian KC; Costner MI; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; Van Vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AG; Sigler L; Hameed S; Pham N; Brey R; Weisman MH; McGwin G; Magder LS; Petri M
    Lupus; 2015 Jan; 24(1):42-9. PubMed ID: 25124676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
    J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
    Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis.
    Atta AM; Pereira MM; Santiago M; Sousa-Atta ML
    Clin Rheumatol; 2009 Jun; 28(6):693-7. PubMed ID: 19283331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
    Caccavo D; Rigon A; Picardi A; Galluzzo S; Vadacca M; Ferri GM; Amoroso A; Afeltra A
    Clin Rheumatol; 2005 Aug; 24(4):381-7. PubMed ID: 15592902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G; Al-Barshomy SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP; Trabandt A; Grobe N; Werle E
    Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.